ArticleJournal of neuro-oncology2026
Neighborhood material deprivation and days at home after glioblastoma diagnosis.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine the association between neighborhood material deprivation and days at home (DAH) after glioblastoma diagnosis.
methodsThis population-based retrospective cohort study used linked administrative data from Ontario, Canada, for adults diagnosed with glioblastoma during 2003-2023. Material deprivation was assigned using Ontario Marginalization Index quintiles (Q1, least deprived; Q5, most deprived). The primary outcome was DAH within 365 days, defined as days alive outside acute hospitals, inpatient rehabilitation, and continuing or complex care. The primary analysis included diagnoses through 2022. Median quantile regression adjusted for age, sex, comorbidity, frailty, rurality, and diagnosis year. Secondary outcomes included other DAH horizons and overall survival.
resultsAmong 9172 adults, 4491 (49.0%) were younger than 65 years and 5435 (59.3%) were male. Median DAH-365 was 249 days (interquartile range, 67-350) in Q1 and 138 (27-332) in Q5. In 8234 complete cases, adjusted median differences versus Q1 were - 8.8 days for Q2 (95% confidence interval [CI], - 19.6 to 2.0), - 14.8 for Q3 (- 27.0 to - 2.6), - 18.3 for Q4 (- 29.4 to - 7.2), and - 36.2 for Q5 (- 51.5 to - 20.9). Median survival was 324 days (95% CI, 306-343) in Q1 and 225 (211-244) in Q5.
conclusionGreater neighborhood material deprivation was associated with substantially fewer DAH after glioblastoma diagnosis. The adjusted gap exceeding 5 weeks supports investigation of treatment access and supportive care pathways to inform efforts to improve equity.
Indexed as
Identifiers
42907721What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.